An electrode system for an implantable cardioverter defibrillator. The electrode system includes a conductive structure which is physically and electrically connected to the housing or can of the implantable cardioverter defibrillator and is used as an electrode in combination with an existing implantable cardioverter defibrillator electrode or electrodes. The electrode system provides a therapeutically significant increase in the effective surface area of the implantable cardioverter defibrillator's electrodes without requiring an additional header connection, feedthru, or cable.

Patent
   5531766
Priority
Jan 23 1995
Filed
Jan 23 1995
Issued
Jul 02 1996
Expiry
Jan 23 2015
Assg.orig
Entity
Small
129
8
EXPIRED
1. In an implantable cardioverter defibrillator pulse generator including a housing having an exterior surface, an interior surface defining a sealed interior space containing pulse generation circuitry, and means, disposed on said exterior surface, to connect an external electrode to said pulse generation circuitry, the combination with said cardioverter defibrillator pulse generator of a conductive tail electrode physically connected to said exterior surface of said housing, said tail electrode having a predetermined surface area, said tail electrode further having a length of 2-30 cm. and a diameter of 0.5-10 mm.
11. In an implantable cardioverter defibrillator pulse generator including a housing having an exterior surface, an interior surface defining a sealed interior space containing pulse generation circuitry, and means, disposed on said exterior surface, to connect an external electrode to said pulse generation circuitry, said housing exterior surface comprising a conductive, metallic portion which is electrically connected to the pulse generation circuitry, the combination with said cardioverter defibrillator pulse generator of a conductive tail electrode physically connected to said exterior surface of said housing, said tail electrode having a first predetermined surface area, said tail electrode further having a length of 2-30 cm. and a diameter of 0.5-10 mm., and said tail electrode being electrically connected to said housing exterior surface, whereby said housing exterior surface and said tail electrode cooperate to yield a composite electrode surface area of a second predetermined surface area.
12. A pulse generator for use in an implantable cardioverter defibrillator system having at least one externally connected electrode, comprising:
(a) pulse generation circuitry;
(b) a housing having an exterior surface, an interior surface defining a sealed interior space containing said pulse generation circuitry, and means, disposed on said exterior surface, to connect an external electrode to said pulse generation circuitry, said housing exterior surface comprising a conductive, metallic portion which is electrically connected to the pulse generation circuitry;
(c) a metallic, conductive connection tube welded to said housing; and
(d) an elongated, flexible conductive tail electrode of a predetermined length connected to said exterior surface of said housing via said connection tube, said tail electrode having a first predetermined surface area, said tail electrode further having a length of 10-20 cm and a diameter of 1.0-5.0 mm., said tail electrode further being electrically connected to said housing exterior surface, whereby said housing exterior surface and said tail electrode cooperate to yield a composite electrode surface area of a second, greater, predetermined surface area.
2. The implantable cardioverter defibrillator pulse generator of claim 1, wherein said housing exterior surface comprises a conductive, metallic portion which is electrically connected to the pulse generation circuitry, and wherein said tail electrode is electrically connected to said housing exterior surface, whereby said housing exterior surface and said tail electrode cooperate to yield a composite electrode surface area.
3. The implantable cardioverter defibrillator pulse generator of claim 2, wherein said housing exterior surface conductive portion is constructed of a material selected from the group of materials consisting of titanium, MP35N, stainless steel and platinum.
4. The implantable cardioverter defibrillator pulse generator of claim 2, further comprising means to connect said electrode tail to said housing exterior surface.
5. The implantable cardioverter defibrillator pulse generator of claim 4, wherein said means to connect said electrode tail to said housing exterior surface comprises a tube which is closed at one end and open at an opposite, flanged end, said tube being inserted in and welded to an aperture in said housing exterior surface, said tail electrode being inserted in said open, ranged end and said tube being crimped to retain said tail electrode therein.
6. The implantable cardioverter defibrillator pulse generator of claim 5, wherein said tube closed end is further disposed in an aperture in said housing exterior surface.
7. The implantable cardioverter defibrillator pulse generator of claim 1, wherein said tail electrode is constructed of metal wire selected from the group consisting of titanium, MP35N, stainless steel and platinum wires.
8. The implantable cardioverter defibrillator pulse generator of claim 1, wherein said tail electrode is constructed of metal cable selected from the group consisting of titanium, MP35N, stainless steel and platinum cables.
9. The implantable cardioverter defibrillator pulse generator of claim 1, wherein said tail electrode is an elongated, flexible structure.
10. The implantable cardioverter defibrillator pulse generator of claim 1, where said tail electrode has a length of 10-20 cm. and a diameter of 1.0-5.0 mm.

1. Field of the Invention

This invention relates to medical devices, and more particularly to implantable cardioverter defibrillators (ICD) used to cardiovert and/or defibrillate a human being. The ICD pulse generator kite-tail electrode system of this invention improves the performance of ICDs.

2. Background Information

The implantable cardioverter defibrillator is a well established therapy for malignant ventricular arrhythmia. The ICD senses an arrhythmia, stores a charge in an internal capacitor, and delivers that charge to the heart through electrodes.

An early form of electrodes are epicardial or pericardial patches which are sewn to the surface of the heart. Electrodes of this type are shown in FIG. 1. Epicardial or pericardial patch electrodes are disclosed in U.S. Pat. No. 4,821,723 to Baker, Jr. et al. and U.S. Pat. No. 4,827,932 to Ideker, et al. Another well know form of electrodes are endocardial lead electrodes which traverse the patient's vasculature and are disposed within the heart, preferably the right ventricle. A hybrid system uses endocardial leads in conjunction with epicardial patches. This system is disclosed in U.S. Pat. No. 4,548,203 to Tacker, Jr. et al. and U.S. Pat. No. 4,641,656 to Smits.

Most electrode systems which utilize epicardial patches require open chest surgery for implantation and positioning. Such surgery is traumatic, risky, expensive and requires a long patient recovery period. Referring to FIG. 2, procedures were therefore developed to subcutaneously implant a patch electrode in the left side of the patents chest or in the back under the shoulder blade. U.S. Pat. No. 4,662,377 to Hileman et al. teaches such a method. U.S. Pat. No. 4,727,877 to Kallock and U.S. Pat. No. 5,014,696 to Mehra disclose a similar method wherein a rigid plate is used in place of a patch. The advantage of these subcutaneous implantation methods is that major surgery is avoided, while at the same time improved performance is provided by the combination of the large surface area electrode element with the endocardial lead electrode.

Another approach used is to pericardially implant an electrode. In such systems, an electrode is implanted near the epicardial surface of the heart via an insertion through a small incision or an introducer apparatus. The electrodes simulate the epicardial electrodes, but avoid the trauma of open chest surgery. Pericardial electrodes and methods are disclosed in U.S. Pat. No. 4,860,769 to Fogarty et al. and U.S. Pat. No. 4,991,578 to Cohen.

Referring to FIG. 3, a recent development in ICD electrodes is the "pitchfork electrode" disclosed in U.S. Pat. No. 5,203,348 to Dahl, et al. This approach replaces the large surface area of the subcutaneous patch style electrode comprising three parallel wires forced about the patient's left side. Although the surface area of the electrodes is not great, the convex hull "outline" or "shadow" formed by the wires is large. This technique results in a very low impedance and also low defibrillation energy thresholds. Unfortunately, the implantation technique is complex and time consuming. Also, the low impedance is not consistent with the modem trend toward smaller ICD capacitance's which show the most benefit with high impedance.

Referring to FIG. 4, another recent electrode system approach is to use the housing or can of the ICD pulse generator as an electrode in conjunction with an endocardial lead electrode. This technique is shown in published European Patent Application 0453761A1 and in U.S. Pat. No. 5,133,353 to Hauser, U.S. Pat. No. 5,261,400 to Bardy and in U.S. Pat. No. 5,376,103 to Anderson. This approach, although it has advantages, is inconsistent with another trend in ICD design, namely that toward smaller ICD housing. Smaller housings will reduce the effective size of the electrode formed thereby, which will yield reduced performance. Anderson teaches the use of a subcutaneous electrode in conjunction with the ICD housing electrode, but this technique requires the addition of an external connection to the housing and the attendant complication of connectors, feedthrus, and cables, as well as the resultant increase in size of the housing, to accommodate the connector and feedthru.

Despite the need in the art for a safe, easy to implant, effective, and reliable electrode system for use with an ICD, and which overcomes the disadvantages, shortcomings and limitations of the prior art, none insofar as is known has been developed or proposed.

Accordingly, it is an object of the present invention to provide a new electrode system for use with an ICD. It is a further object of this invention to provide an electrode system which is safe, easy to implant, reliable and effective, and which overcomes the limitations and shortcomings of the prior art.

The present invention provides an electrode system for an implantable cardioverter defibrillator, including a conductive structure which is physically and electrically connected to the housing or can of the implantable cardioverter defibrillator and is used as an electrode in combination with an existing implantable cardioverter defibrillator electrode or electrodes. The electrode system provides a significant increase in the effective surface area of the implantable cardioverter defibrillator's electrodes.

In a basic aspect, the invention includes an implantable cardioverter defibrillator pulse generator including a housing having an exterior surface, an interior surface defining a sealed interior space containing pulse generation circuitry, and means, disposed on the exterior surface, to connect an external electrode to the pulse generation circuitry, wherein the improvement comprises, a conductive tail electrode physically connected to the exterior surface of the housing, the tail electrode having a predetermined surface area.

In a preferred embodiment, the invention yields a pulse generator for use in an implantable cardioverter defibrillator system having at least one externally connected electrode, comprising:

(a) pulse generation circuitry;

(b) a housing having an exterior surface, an interior surface defining a sealed interior space containing the pulse generation circuitry, and means, disposed on the exterior surface, to connect an external electrode to the pulse generation circuitry, the housing exterior surface comprising a conductive, metallic portion which is electrically connected to the pulse generation circuitry;

(c) a metallic, conductive connection tube connected to the housing; and

(d) an elongated, flexible conductive tail electrode of a predetermined length connected to the exterior surface of the housing via the connection robe, the tail electrode having a first predetermined surface area, the tail electrode further being electrically connected to the housing exterior surface, whereby the housing exterior surface and the tail electrode cooperate to yield a composite electrode surface area of a second, greater, predetermined surface area.

The features, benefits and objects of this invention will become clear to those skilled in the art by reference to the following description, claims and drawings.

FIG. 1 illustrates the prior art ICD electrode system having at least one epicardial patch electrode attached directly to the heart.

FIG. 2 illustrates the prior art ICD electrode system having an epicardial patch electrode and an endocardial lead electrode disposed within a chamber of the heart.

FIG. 3 illustrates the prior art ICD electrode system having a subcutanteously implanted "pitchfork" style electrode in combination with an endocardial lead electrode.

FIG. 4 illustrates the prior art ICD electrode system wherein the housing of the ICD pulse generator is utilized as an electrode in combination with an endocardial lead electrode.

FIG. 5 illustrates the ICD electrode system of the present invention, one embodiment of which comprises a kite-tail member attached to a pulse generator and working in combination with an endocardial lead electrode.

FIG. 6 is a plan view of an embodiment of the ICD electrode system of this invention.

FIG. 7 is a detailed view of an embodiment of the ICD electrode system of this invention.

The implantable cardioverter defibrillator is an important tool for managing the health of patients who have a history of heart problems. The ICD effects defibrillation of the human heart by passing a current through the heart for a predetermined time period. A voltage is generated in the ICD pulse generator and transmitted to the heart through electrodes. To successfully defibrillate an exemplary heart with a given set of electrodes, a current of approximately 6-11.5 A is required to produce a pulse width of 13-2 ms., respectively.

The present invention provides an electrode system for an implantable cardioverter defibrillator. Referring to FIG. 5, the ICD electrode system 10 of the present invention basically comprises an implantable pulse generator 11, an endocardial lead 12 connected to the pulse generator 11 via connection ports, and a kite-tail electrode 13 connected directly to the housing of the pulse generator 11.

The ICD pulse generator 11 is a sealed, canister-like unit which is implanted in the patient's body 14 and contains various electronic components. Implantation is made subcutaneously in the left chest area of the patient 14. The internal components (not shown) of the pulse generator 11 comprise a battery, charge storage means, preferably one or more capacitors, connected to the battery, electrode connection means connectable to the charge storage means and connected to the electrodes when in an operative orientation, and switch means connected to the charge storage means and to the electrode connection means for controlling the delivery of a high voltage defibrillation pulse, of a predetermined polarity, to the patient 14. The aforementioned internally disposed electrical components are well known in the art.

The endocardial lead electrode 12 is of a design which is known in the art. The electrode 12 extends from the implanted pulse generator canister 11 through the vascular system of the patient 14 to the heart 15. The endocardial lead electrode 12 preferably comprises at least two metallic or semi-metallic electrode members which are disposed in the chamber(s) of the heart 15. The electrode members typically are formed of coiled metal bands. Each electrode member is connected to an elongated conductive lead or wire. The leads are encased in a non-conductive sheath. The leads terminate in connectors which are attached to the pulse generator 11.

FIG. 6 shows a preferred embodiment of the pulse generator 11. The pulse generator 11 has a housing or can 19 which has a hollow interior for containing the aforementioned electrical components. The housing 19 may be oval, rectangular or irregularly shaped and is constructed of a non-reactive metal, preferably titanium. A header 20, preferably constructed of a polymeric material or non-reactive metal, is sealingly disposed at the top of the housing 19. The header 20 has a pair of electrode connectors 21 a and b. The electrode connectors 21 a and b are connectable, as is known in the art, to the endocardial lead electrode connectors located at the terminal end of the endocardial lead electrode leads. The connectors 21 a and b are connected to conductive leads which extend through apertures (not shown) in the header 21 into the interior of the pulse generator 11, where they are communicatively connected to the circuit components thereof The apertures are designed with known feedthru structures which seal and isolate the pulse generator 11 interior from the patient. Although the pulse generator 11 is preferably of the type wherein the metal housing 19 functions as an electrode in the ICD system 10, in conjunction with the endocardial electrode 12 or any other electrode or electrodes, it is within the purview of the invention that the housing not function as an electrode.

The kite tail electrode 22 is a thin, elongated structure of a predetermined length with proximal and distal ends 23 and 24, respectively. The tail electrode 22 has a length of 2-30 cm., and preferably 10-20 cm. The electrode 22 is constructed of metallic wire or cable, preferably composed of titanium, MP35N, stainless steel, or platinum. The overall diameter of the tail electrode 22 is 0.5-10 mm. A 1.0-5 mm diameters is preferred as a best compromise between compactness and strength.

Referring also to FIG. 7, a connection tube 25 with one closed end 26 and an open end 27 with a circumferential, low profile flange 32 is disposed on the exterior surface 29 of the can 19. The connection tube 25 is preferably constructed of titanium and has an inside diameter and depth sufficient to allow insertion of the tail electrode 22 proximal end 23 therein. The closed end 26 of the flanged tube 25 is inserted and the flange 32 is welded 30 at an aperture 28 in the titanium can 19 at a predetermined point, for example the edge opposite the header 20.

The proximal end 23 of the electrode 22 is inserted into the open, flanged end 27 of the connection tube 25. The connection tube 25 is then crimped interiorly to hold the electrode 22 in place. The crimped tube connector structure 25 maintains the hermetic seal between inside 31 and outside 29 surfaces of the pulse generator 11. If removal of the electrode tail 22 is required, for any reason, it may easily be cut loose, or in the alternative, freed by a sharp tug on the electrode tail 22. Full withdrawal of the electrode tail 22 from the patient body 14 may then be easily accomplished. After withdrawal of the electrode tail 22, a smooth non-irritating surface remains on the can 19. Importantly, the hermeticity of the interior 31 of the pulse generator 11 is maintained without the use of additional feedthru mechanism.

In one alternative embodiment, the welded flange tube is reusable to allow the removal of the tail or substitution of various tail lengths. In another alternative embodiment, the distal end of the kite tail electrode 22 may additionally have either molded tines or a molded tie-down section to firmly fixate the distal end of the electrode. Such fixation prevents any wandering of the electrode from its inserted, tested position. In yet another alternative embodiment, the electrode tail can be inserted or extracted repeatedly. The device has a terminal block in the header that is tied to the housing of the pulse generator. Fixation of the electrode tail to the block is made via a set screw or a similar positive locking mechanism.

In summary, the kite-tail electrode 22 is a conductive structure which is physically and electrically connected to the exterior of the housing 19 of the pulse generator 11 of the implantable cardioverter defibrillator 10 and is used as an electrode in combination with the endocardial lead electrode 12 and/or other electrodes. This electrode 22 provides a significant increase in the overall effective electrode surface area of the ICD system 10. The increased electrode surface area is believed to be therapeutically significant. Importantly, the electrode of this invention utilizes a direct metallic and conductive extension of the can or housing, and hermeticity is maintained with no connection through the header assembly and associated feedthru devices.

As many changes are possible to the embodiments of this invention utilizing the teachings thereof, the descriptions above, and the accompanying drawings should be interpreted in the illustrative and not the limited sense.

Kroll, Mark W., Adams, Theodore P., Nelson, Randall S.

Patent Priority Assignee Title
10016609, Feb 07 2007 Cameron Health, Inc. Sensing vector selection in a cardiac stimulus device with postural assessment
10052487, Jan 25 2005 Cameron Health, Inc. Methods and devices for adapting charge initiation for an implantable defibrillator
10183171, May 29 2003 Cameron Health, Inc. Method for discriminating between ventricular and supraventricular arrhythmias
10575740, May 26 2006 CAMERON HEALTH INC. Systems and methods for sensing vector selection in an implantable medical device
11020602, May 29 2003 Cameron Health, Inc. Method for discriminating between ventricular and supraventricular arrhythmias
11083897, Jan 25 2005 Cameron Health, Inc. Methods and devices for adapting charge initiation for an implantable defibrillator
5709709, Feb 13 1996 Angeion Corporation ICD with rate-responsive pacing
5814076, Feb 09 1996 SIRROM CAPITAL CORPORATION Apparatus for improved cardiac pacing and sensing using extracardiac indifferent electrode configurations
6091989, Apr 08 1998 Imperception, Incorporated Method and apparatus for reduction of pain from electric shock therapies
6721597, Sep 18 2000 CAMERON HEALTH, INC Subcutaneous only implantable cardioverter defibrillator and optional pacer
6754528, Nov 21 2001 CAMERON HEALTH, INC Apparatus and method of arrhythmia detection in a subcutaneous implantable cardioverter/defibrillator
6778860, Nov 05 2001 CAMERON HEALTH, INC Switched capacitor defibrillation circuit
6834204, Nov 05 2001 CAMERON HEALTH, INC Method and apparatus for inducing defibrillation in a patient using a T-shock waveform
6856835, Sep 18 2000 CAMERON HEALTH, INC Biphasic waveform for anti-tachycardia pacing for a subcutaneous implantable cardioverter-defibrillator
6866044, Sep 18 2000 CAMERON HEALTH, INC Method of insertion and implantation of implantable cardioverter-defibrillator canisters
6937907, Sep 18 2000 CAMERON HEALTH, INC Subcutaneous electrode for transthoracic conduction with low-profile installation appendage and method of doing same
6950705, Sep 18 2000 CAMERON HEALTH, INC Canister designs for implantable cardioverter-defibrillators
6952610, Sep 18 2000 CAMERON HEALTH, INC Current waveforms for anti-tachycardia pacing for a subcutaneous implantable cardioverter- defibrillator
6988003, Sep 18 2000 CAMERON HEALTH, INC Implantable cardioverter-defibrillator having two spaced apart shocking electrodes on housing
7039459, Sep 18 2000 CAMERON HEALTH, INC Cardioverter-defibrillator having a focused shocking area and orientation thereof
7039465, Sep 18 2000 CAMERON HEALTH, INC Ceramics and/or other material insulated shell for active and non-active S-ICD can
7043299, Sep 18 2000 CAMERON HEALTH, INC Subcutaneous implantable cardioverter-defibrillator employing a telescoping lead
7062329, Oct 04 2002 CAMERON HEALTH, INC Implantable cardiac system with a selectable active housing
7065407, Sep 18 2000 CAMERON HEALTH, INC Duckbill-shaped implantable cardioverter-defibrillator canister and method of use
7065410, Sep 18 2000 CAMERON HEALTH, INC Subcutaneous electrode with improved contact shape for transthorasic conduction
7069080, Sep 18 2000 CAMERON HEALTH, INC Active housing and subcutaneous electrode cardioversion/defibrillating system
7076294, Sep 18 2000 Cameron Health, Inc. Method of implanting ICD and subcutaneous lead
7076296, Sep 18 2000 CAMERON HEALTH, INC Method of supplying energy to subcutaneous cardioverter-defibrillator and pacer
7090682, Sep 18 2000 CAMERON HEALTH, INC Method and apparatus for extraction of a subcutaneous electrode
7092754, Sep 18 2000 CAMERON HEALTH, INC Monophasic waveform for anti-bradycardia pacing for a subcutaneous implantable cardioverter-defibrillator
7120495, Sep 18 2000 CAMERON HEALTH, INC Flexible subcutaneous implantable cardioverter-defibrillator
7120496, Sep 18 2000 Cameron Health, Inc. Radian curve shaped implantable cardioverter-defibrillator canister
7146212, Sep 18 2000 CAMERON HEALTH, INC Anti-bradycardia pacing for a subcutaneous implantable cardioverter-defibrillator
7149575, Sep 18 2000 CAMERON HEALTH, INC Subcutaneous cardiac stimulator device having an anteriorly positioned electrode
7181274, Sep 18 2000 Cameron Health, Inc. Methods for inducing fibrillation utilizing subcutaneous electrodes
7191009, Aug 09 2004 Medtronic, Inc. Means for increasing implantable medical device electrode surface area
7194302, Sep 18 2000 CAMERON HEALTH, INC Subcutaneous cardiac stimulator with small contact surface electrodes
7194309, Sep 18 2000 CAMERON HEALTH, INC Packaging technology for non-transvenous cardioverter/defibrillator devices
7239925, Sep 18 2000 Cameron Health, Inc. Subcutaneous electrode for transthoracic conduction with improved installation characteristics
7248921, Jun 02 2003 CAMERON HEALTH, INC Method and devices for performing cardiac waveform appraisal
7274962, Sep 18 2000 Cameron Health, Inc. Subcutaneous electrode with improved contact shape for transthoracic conduction
7299092, Sep 18 2000 Cameron Health, Inc. Subcutaneous electrode for transthoracic conduction with low profile installation appendage
7299097, Sep 18 2000 Cameron Health, Inc. Subcutaneous electrode for transthoracic conduction with insertion tool
7302300, Sep 18 2000 Cameron Health, Inc. Subcutaneous electrode for transthoracic conduction with highly maneuverable insertion tool
7330757, Nov 21 2001 CAMERON HEALTH, INC Method for discriminating between ventricular and supraventricular arrhythmias
7349736, Sep 18 2000 CAMERON HEALTH, INC Active housing dual lead assembly
7359754, Sep 18 2000 Cameron Health, Inc. Optional use of a lead for a unitary subcutaneous implantable cardioverter-defibrillator
7363083, Sep 18 2000 Cameron Health, Inc. Flexible subcutaneous implantable cardioverter-defibrillator
7376458, Nov 29 2004 CAMERON HEALTH, INC Method for defining signal templates in implantable cardiac devices
7379772, Nov 21 2001 Cameron Health, Inc. Apparatus and method of arrhythmia detection in a subcutaneous implantable cardioverter/defibrillator
7392085, Nov 21 2001 CAMERON HEALTH, INC Multiple electrode vectors for implantable cardiac treatment devices
7406350, Sep 18 2000 Cameron Health, Inc. Subcutaneous implantable cardioverter-defibrillator employing a telescoping lead
7428437, Sep 18 2000 Cameron Health, Inc. Canister designs for implantable cardioverter-defibrillators
7444182, Nov 21 2001 Cameron Health, Inc. Method for discriminating between ventricular and supraventricular arrhythmias
7463924, Sep 18 2000 Cameron Health, Inc. Methods for determining placement of an implantable cardiac stimulus device
7477935, Nov 29 2004 CAMERON HEALTH, INC Method and apparatus for beat alignment and comparison
7502645, Sep 18 2000 Cameron Health, Inc. Current waveforms for anti-bradycardia pacing for a subcutaneous implantable cardioverter-defibrillator
7536222, Sep 18 2000 Cameron Health, Inc. Nonvascular implantable defibrillator and method
7555338, Apr 26 2005 CAMERON HEALTH, INC Methods and implantable devices for inducing fibrillation by alternating constant current
7616997, Sep 27 2000 CVRX, INC Devices and methods for cardiovascular reflex control via coupled electrodes
7623909, May 26 2006 Cameron Health, Inc.; CAMERON HEALTH, INC Implantable medical devices and programmers adapted for sensing vector selection
7623913, Aug 01 2006 Cameron Health, Inc.; CAMERON HEALTH, INC Implantable medical devices using heuristic filtering in cardiac event detection
7623916, Dec 20 2006 CAMERON HEALTH, INC Implantable cardiac stimulus devices and methods with input recharge circuitry
7623920, Nov 05 2001 Cameron Health, Inc. Low power A/D converter
7627367, Nov 21 2001 Cameron Health, Inc. Multiple electrode vectors for implantable cardiac treatment devices
7627375, Sep 18 2000 Cameron Health, Inc. Implantable cardiac stimulus methods
7650188, Aug 09 2004 Medtronic, Inc Means for augmenting medical electrical systems
7655014, Dec 06 2004 CAMERON HEALTH, INC Apparatus and method for subcutaneous electrode insertion
7657311, Sep 18 2000 Cameron Health, Inc. Subcutaneous only implantable cardioverter-defibrillator and optional pacer
7657322, Sep 18 2000 Cameron Health, Inc. Subcutaneous electrode with improved contact shape for transthoracic conduction
7720534, Sep 18 2000 Cameron Health, Inc. Transthoracic impedance measurement in a subcutaneous device
7720536, Sep 18 2000 Cameron Health, Inc. Power supply for an implantable subcutaneous cardioverter-defibrillator
7751885, Sep 18 2000 Cameron Health, Inc. Bradycardia pacing in a subcutaneous device
7774058, Sep 18 2000 CAMERON HEALTH, INC Anterior positioning on opposing sides of sternum
7774059, Sep 18 2000 CAMERON HEALTH, INC Anterior positioning inactive housing
7783340, Jan 16 2007 CAMERON HEALTH,INC Systems and methods for sensing vector selection in an implantable medical device using a polynomial approach
7813797, Sep 18 2000 Cameron Health, Inc. Cardioverter-defibrillator having a focused shocking area and orientation thereof
7813812, Sep 27 2000 CVRX, INC Baroreflex stimulator with integrated pressure sensor
7835790, Sep 18 2000 CAMERON HEALTH, INC Anterior active housing subcutaneous positioning methods
7840271, Sep 27 2000 CVRx, Inc. Stimulus regimens for cardiovascular reflex control
7877139, Sep 22 2006 Cameron Health, Inc. Method and device for implantable cardiac stimulus device lead impedance measurement
7949400, Sep 27 2000 CVRX, INC Devices and methods for cardiovascular reflex control via coupled electrodes
7991459, Nov 29 2004 Cameron Health, Inc. Method for defining signal templates in implantable cardiac devices
8014851, Sep 26 2006 Cameron Health, Inc. Signal analysis in implantable cardiac treatment devices
8014862, Sep 18 2000 CAMERON HEALTH, INC Anterior active housing subcutaneous positioning methods
8060206, Sep 27 2000 CVRX, INC Baroreflex modulation to gradually decrease blood pressure
8086314, Sep 27 2000 CVRX, INC Devices and methods for cardiovascular reflex control
8116867, Aug 04 2005 Cameron Health, Inc. Methods and devices for tachyarrhythmia sensing and high-pass filter bypass
8160697, Jan 25 2005 CAMERON HEALTH, INC Method for adapting charge initiation for an implantable cardioverter-defibrillator
8160699, Sep 18 2000 Cameron Health, Inc. Cardioverter-defibrillator having a focused shocking area and orientation thereof
8200341, Feb 07 2007 CAMERON HEALTH, INC Sensing vector selection in a cardiac stimulus device with postural assessment
8224437, Oct 22 2003 CVRx, Inc. Baroreflex activation for sedation and sleep
8229563, Jan 25 2005 CAMERON HEALTH, INC Devices for adapting charge initiation for an implantable cardioverter-defibrillator
8290595, Oct 29 2002 CVRX, INC Method and apparatus for stimulation of baroreceptors in pulmonary artery
8412320, Sep 18 2000 Cameron Health, Inc. Nontransvenous and nonepicardial methods of cardiac treatment and stimulus
8447398, Sep 18 2000 CAMERON HEALTH, INC Subcutaneous implantable cardioverter-defibrillator placement methods
8478414, Oct 22 2003 CVRx, Inc. Baroreflex activation for pain control, sedation and sleep
8532767, May 10 2011 Biotronik SE & Co. KG Device for medical applications and electromedical implant
8560076, Oct 22 2003 CVRx, Inc. Devices and methods for electrode implantation
8583236, Mar 27 2002 CVRx, Inc. Devices and methods for cardiovascular reflex control
8606359, Sep 27 2000 CVRX, INC System and method for sustained baroreflex stimulation
8626285, Jun 02 2003 Cameron Health, Inc. Method and devices for performing cardiac waveform appraisal
8644956, Jul 08 2008 BIOTRONIK SE & CO KG Shock electrode line
8670826, Jan 25 2005 Cameron Health, Inc. Methods and devices for adapting charge initiation for an implantable defibrillator
8712531, Sep 27 2000 CVRx, Inc. Automatic baroreflex modulation responsive to adverse event
8718789, Sep 27 2000 CVRx, Inc. Electrode structures and methods for their use in cardiovascular reflex control
8718793, Aug 01 2006 CAMERON HEALTH, INC Electrode insertion tools, lead assemblies, kits and methods for placement of cardiac device electrodes
8755907, Oct 22 2003 CVRx, Inc. Devices and methods for electrode implantation
8781602, Feb 07 2007 Cameron Health, Inc. Sensing vector selection in a cardiac stimulus device with postural assessment
8788023, May 26 2006 Cameron Health, Inc.; CAMERON HEALTH, INC Systems and methods for sensing vector selection in an implantable medical device
8838246, Sep 27 2000 CVRX, INC Devices and methods for cardiovascular reflex treatments
8880190, Sep 27 2000 CVRx, Inc. Electrode structures and methods for their use in cardiovascular reflex control
8942802, May 29 2003 Cameron Health, Inc. Method for discriminating between ventricular and supraventricular arrhythmias
8965530, Feb 07 2007 Cameron Health, Inc. Implantable cardiac devices and methods using an x/y counter
9022962, Nov 22 2000 Boston Scientific Scimed, Inc. Apparatus for detecting and treating ventricular arrhythmia
9044609, Sep 27 2000 CVRx, Inc. Electrode structures and methods for their use in cardiovascular reflex control
9144683, Sep 18 2000 Cameron Health, Inc. Post-shock treatment in a subcutaneous device
9149645, Mar 11 2013 Cameron Health, Inc. Methods and devices implementing dual criteria for arrhythmia detection
9155485, May 29 2003 Cameron Health, Inc. Method for discriminating between ventricular and supraventricular arrhythmias
9216284, Aug 01 2006 Cameron Health, Inc. Electrode insertion tools, lead assemblies, kits and methods for placement of cardiac device electrodes
9357969, Feb 07 2007 Cameron Health, Inc. Sensing vector selection in a cardiac stimulus device with postural assessment
9364677, May 26 2006 Cameron Health, Inc. Systems and methods for sensing vector selection in an implantable medical device
9421390, Mar 11 2013 CAMERON HEALTH INC. Methods and devices implementing dual criteria for arrhythmia detection
9427583, Sep 27 2000 CVRx, Inc. Electrode structures and methods for their use in cardiovascular reflex control
9555259, May 29 2003 CAMERON HEALTH INC. Method for discriminating between ventricular and supraventricular arrhythmias
9579065, Mar 12 2013 CAMERON HEALTH INC. Cardiac signal vector selection with monophasic and biphasic shape consideration
9744366, Feb 07 2007 Cameron Health, Inc. Sensing vector selection in a cardiac stimulus device with postural assessment
9844678, Mar 11 2013 Cameron Health, Inc. Methods and devices implementing dual criteria for arrhythmia detection
9968796, May 29 2003 Cameron Health, Inc. Method for discriminating between ventricular and supraventricular arrhythmias
Patent Priority Assignee Title
3478746,
3735766,
3920888,
4549548, Sep 14 1983 VITATRON MEDICAL B V , A CORP OF THE NETHERLANDS Pacemaker system with automatic event-programmed switching between unipolar and bipolar operation
5235978, Mar 10 1992 Pacesetter AB Implantable arrangement for the defibrillation or cardioversion of a heart
5241960, Jul 08 1992 ELA MEDICAL, S A Defibrillator pulse generator
5376103, Mar 19 1992 ELA MEDICAL, S A Electrode system for implantable defibrillator
5405363, Mar 15 1991 ELA MEDICAL, S A Implantable cardioverter defibrillator having a smaller displacement volume
///
Executed onAssignorAssigneeConveyanceFrameReelDoc
Jan 23 1995Angeion Corporation(assignment on the face of the patent)
Jan 18 1999Angeion CorporationNORWEST BUSINESS CREDIT, INC SECURITY INTEREST SEE DOCUMENT FOR DETAILS 0096930097 pdf
Dec 02 1999NORWEST BUSINESS CREDIT, INC N K A WELLS FARGO BUSINESS CREDIT, INC Angeion CorporationRELEASE OF SECURITY INTEREST0104700293 pdf
Date Maintenance Fee Events
Jan 25 2000REM: Maintenance Fee Reminder Mailed.
Jul 02 2000EXP: Patent Expired for Failure to Pay Maintenance Fees.


Date Maintenance Schedule
Jul 02 19994 years fee payment window open
Jan 02 20006 months grace period start (w surcharge)
Jul 02 2000patent expiry (for year 4)
Jul 02 20022 years to revive unintentionally abandoned end. (for year 4)
Jul 02 20038 years fee payment window open
Jan 02 20046 months grace period start (w surcharge)
Jul 02 2004patent expiry (for year 8)
Jul 02 20062 years to revive unintentionally abandoned end. (for year 8)
Jul 02 200712 years fee payment window open
Jan 02 20086 months grace period start (w surcharge)
Jul 02 2008patent expiry (for year 12)
Jul 02 20102 years to revive unintentionally abandoned end. (for year 12)